Clinical trial Recruiting at 2 sites Interventional Ages 6 to 21

Home-based neuromodulation therapy for children with cerebral palsy

Official title: A Novel Home-based Non-invasive Neuromodulation Therapy for Children and Adolescents With Cerebral Palsy

Run by KK Women's and Children's Hospital · NCT06921538 · Data updated 2026-11-12

This study is testing a new home therapy using electrical stimulation to see if it can help children and teens with cerebral palsy improve their movement and reduce stiffness.

Quick facts

Study typeInterventional
Ages6 Years to 21 Years
SexAll
Enrollment60 (estimated)
SponsorKK Women's and Children's Hospital
Government
Locations2 sites (Singapore and 1 other locations)
StatusRecruiting
StartedOctober 11, 2024
Main results expectedNovember 2025
Study endsNovember 2025
Registry record updatedApril 10, 2025
Trial IDNCT06921538 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children and adolescents aged 2 to under 21 with mild to severe spastic cerebral palsy classified as GMFCS II, III, IV, or V.

Probably not a fit

Patients with epilepsy who have had recent seizures are unlikely to benefit from this study due to safety concerns.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness, feasibility, and acceptability of a novel home-based non-invasive neuromodulation therapy using the AscenZ-IV Stimulator for children and adolescents with cerebral palsy. The therapy combines transcranial Pulse Current Stimulation (tPCS) and Transcutaneous Electrical Nerve Stimulation (TENS) to improve spasticity and motor function. It aims to provide a less labor-intensive and more affordable alternative to traditional treatments, which can be invasive and costly. The study involves a crossover randomized controlled trial design and includes participants aged 2 to under 21 with varying severity of spastic cerebral palsy.

Why it matters

Potential benefit: If successful, this therapy could significantly improve motor function and reduce spasticity in children with cerebral palsy, enhancing their quality of life.

How similar studies have gone: While this approach is novel, preliminary unpublished data from China suggest potential effectiveness, indicating a need for further validation in this context.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Children and adolescents aged between 2 to \<21 years old with mild to severe Spastic Cerebral Palsy (CP) classified on Gross Motor Function Classification System (GMFCS) II, III, IV, V. Families with at least one parent or caregiver has simple or conversational English language skill.

To be eligible for the qualitative interview components of this research study, the individuals should be recognised as one of the following:

1. CP patients who participate in this research study,
2. caregivers of the CP patients taking part in this research study,
3. implementation staff
4. qualified clinicians not involved in the intervention or refused to recommend the intervention device (AscenZion-IV stimulator) for management of CP.

Eligible individuals must agree to be audio-recorded.

Exclusion Criteria:

1. CP patients with epilepsy with recent seizures (\&lt;12 months) will be excluded for safety given the theoretical risks of seizures (abnormal brain electrical discharges) with transcranial electrical stimulation. We will include those with well controlled epilepsy with no recent seizures (within 12 months).
2. CP patients who have contra-indications to the use of tPCS and/or TENS will be excluded from the study, include:

   * Individuals with history of uncontrolled epileptic disorder, seizures, brain tumour or trauma, and mental disease
   * Individuals with electrical implanted stimulatory device, such as pacemaker or defibrillator
   * Individuals with medical devices that are affected by magnets, such as programmable shunts.
   * Individuals with pregnancy
3. CP patients who received any intramuscular botulinum toxin injections within less than 6 months (as anti-spasticity effect lasts for 4-6 months).
4. CP patients who received any musculo-skeletal, brain or nerve-related surgery within less than 6 months, or major surgery requiring prolonged hospitalisation (\&gt;1week) within less than 3 months.

Those who do not agree to be audio-recorded will be excluded for the qualitative interview components of this research study.

Where it's running

  • National University Hospital Singapore
    Singapore, Singapore
    Recruiting
  • KK Women's and Children's Hospital
    Singapore, Singapore
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.